CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 17,956	$ 42,694
Restricted cash	13,504	3,075
Patient accounts receivable	302,470	274,961
Prepaid expenses	17,011	10,356
Other current assets	37,839	25,598
Total current assets	388,780	356,684
Property and equipment, net of accumulated depreciation of $102,407 and $96,937	17,248	18,435
Operating lease right of use assets	105,843	101,257
Goodwill	1,285,455	1,196,090
Intangible assets, net of accumulated amortization of $11,891 and $19,900	103,678	111,190
Deferred income tax assets	0	289
Other assets	81,123	73,023
Total assets	1,982,127	1,856,968
Current liabilities:
Accounts payable	45,527	38,217
Payroll and employee benefits	145,073	141,001
Accrued expenses	130,100	150,836
Current portion of long-term obligations	12,628	12,995
Current portion of operating lease liabilities	33,872	31,233
Total current liabilities	367,200	374,282
Long-term obligations, less current portion	443,431	432,075
Operating lease liabilities, less current portion	72,030	69,309
Deferred income tax liabilities	15,983	0
Other long-term obligations	13,873	4,979
Total liabilities	912,517	880,645
Commitments and Contingencies—Note 6
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 37,852,059 and 37,674,868 shares issued; and 32,479,475 and 32,509,969 shares outstanding	38	38
Additional paid-in capital	750,914	728,118
Treasury stock, at cost 5,372,584 and 5,164,899 shares of common stock	(461,168)	(435,868)
Retained earnings	725,955	639,063
Total Amedisys, Inc. stockholders’ equity	1,015,739	931,351
Noncontrolling interests	53,871	44,972
Total equity	1,069,610	976,323
Total liabilities and equity	$ 1,982,127	$ 1,856,968